Chinese plant cuts production in pollution snafu

An outcry over pollution from a pharmaceuticals plant in China has the company scrambling to fix the problem. Harbin Pharmaceuticals, which makes active pharmaceutical ingredients for penicillin and cephalosporin drugs, has cut back on production as it works to curb its emissions. Meanwhile, the state-run news service is taking the company to task, saying that there's "no excuse" for allowing discharge of toxic waste. Report

Suggested Articles

Belén Garijo, currently CEO of Merck Healthcare, will succeed Stefan Oschmann as the German company's chief exec when his tenure ends in April 2021.

More than 60 researchers and bioethicists called on Pfizer to take time to collect more COVID-19 vaccine safety data, Bloomberg reports. 

Leaked details about an ad campaign to quell coronavirus fears before the election raise "every red flag I could dream of," an ex-HHS official said.